StudyRareStudyRare

Polyhydramnios and oligohydramnios

Log in to star

Last updated Nov 9, 2026

Log in to add personal notes on this page.

Too much or too little amniotic fluid. After about 16 weeks, amniotic fluid is almost entirely fetal urine, and the main way out is fetal swallowing. So too much fluid means the fetus is not swallowing, the gut is blocked, or the kidneys make too much urine (open skin defects also add fluid). Too little fluid means the kidneys make no urine, the urine cannot get out, or the membranes have ruptured.

Two measures: the deepest vertical pocket (DVP) and the amniotic fluid index (AFI, the deepest pocket in each of four quadrants, summed):

DVPAFI
OligohydramniosLess than 2 cmLess than 5 cm
Polyhydramnios8 cm or more24 or 25 cm or more

Anhydramnios is no measurable fluid. Polyhydramnios affects 1% to 2% of pregnancies.

Ask the scan four questions:

  1. Is the stomach seen? Small or absent: esophageal atresia. Double bubble: duodenal atresia.
  2. Is the bladder seen? Empty with anhydramnios: absent or nonfunctioning kidneys. Large: outlet obstruction. Normal with severe oligohydramnios: ruptured membranes.
  3. Is the fetus moving, and how big is it? Talipes or poor movement: a fetus that cannot swallow. Large: diabetes or overgrowth. Small: aneuploidy or the placenta.
  4. Is there hydrops, or a monochorionic co-twin?

Then the mother: glucose, medications, leaking fluid, and her own muscles.

  • Idiopathic (50% to 60%): normal anatomy and glucose testing, yet a 2- to 5-fold rise in perinatal mortality. A gut atresia may surface only after birth.
  • Maternal diabetes (nearly 15%): increased fetal urination, often with macrosomia. See maternal metabolic teratogens.
  • Gut obstruction: esophageal atresia gives a small or absent stomach bubble; look for VACTERL association and CHARGE syndrome. Duodenal atresia gives a double bubble, with polyhydramnios usually after 24 weeks, and is associated with Down syndrome.
  • A fetus that cannot swallow: congenital myotonic dystrophy type 1 from a maternal DMPK CTG expansion (polyhydramnios with talipes may be the family's first clue); fetal akinesia (see arthrogryposis); trisomy 18; anencephaly and holoprosencephaly; facial clefts and micrognathia (Pierre Robin sequence).
  • Overgrowth: Beckwith-Wiedemann syndrome, with macrosomia, omphalocele, macroglossia, enlarged kidneys, and a large placenta.
  • RASopathies: Noonan syndrome, often after increased nuchal translucency or cystic hygroma. Costello syndrome (HRAS) and cardiofaciocutaneous syndrome, with overgrowth and relative macrocephaly; atrial tachycardia suggests Costello.
  • Antenatal Bartter syndrome: salt wasting in the loop of Henle (SLC12A1, KCNJ1; autosomal recessive) makes the fetus polyuric; the newborn has polyuria, hypokalemia, and hypercalciuria. BSND adds deafness. MAGED2 causes a transient X-linked form with very preterm birth.
  • Fetal anemia and hydrops: alloimmunization, parvovirus B19, fetomaternal hemorrhage, thalassemia. Polyhydramnios may be the first sign. See nonimmune hydrops fetalis.
  • Twin-twin transfusion syndrome: the volume-overloaded recipient is polyuric (DVP over 8 cm) beside an oliguric donor (DVP under 2 cm).
  • Other: placental chorioangioma; congenital infection.
  • Rupture of membranes: the most common cause (50% in one series, ahead of growth restriction at 18% and anomalies at 14%).
  • Bilateral renal agenesis: virtually no fluid from 16 weeks, a persistently empty bladder, no renal arteries on color Doppler. The adrenal glands can be mistaken for kidneys. Consider branchio-oto-renal syndrome (EYA1).
  • Cystic or dysplastic kidneys: autosomal recessive polycystic kidney disease (PKHD1) gives large, bright kidneys with progressive oligohydramnios in the second or third trimester. Also bilateral multicystic dysplasia and Meckel-Gruber syndrome. See cystic kidneys.
  • Lower urinary tract obstruction: posterior urethral valves in a male fetus give a distended, thick-walled bladder, dilated ureters, and a keyhole-shaped posterior urethra.
  • ACE inhibitors or ARBs in the second and third trimesters: fetal hypotension cuts renal blood flow, giving oligohydramnios, renal tubular dysplasia, calvarial hypoplasia, and neonatal anuria. Autosomal recessive renal tubular dysgenesis is the genetic phenocopy. NSAIDs (indomethacin) also lower fetal urine output. See medication teratogens.
  • Placental insufficiency with growth restriction.
  • Donor twin in twin-twin transfusion syndrome.

Potter sequence

Prolonged severe oligohydramnios from any cause produces pulmonary hypoplasia, a compressed face (beaked nose, infraorbital creases, low-set ears, receding chin), and limb deformities such as talipes and contractures. It is a deformation sequence; the real diagnosis is its cause. The lungs are most at risk in the canalicular phase, 16 to 26 weeks: with a pocket under 2 cm between 20 and 25 weeks, survival was 30%, against 98% with 2 cm or more.

  • Polyhydramnios + talipes + reduced movement → congenital myotonic dystrophy type 1; examine the mother.
  • Polyhydramnios + growth restriction → aneuploidy, trisomy 18 first.
  • Polyhydramnios + macrosomia → maternal diabetes first; Beckwith-Wiedemann syndrome with an omphalocele or macroglossia.
  • Severe oligohydramnios + normal-sized bladder → ruptured membranes.
  • Oligohydramnios + skull ossification defect → ACE inhibitor or ARB exposure, or renal tubular dysgenesis.

Polyhydramnios

  1. Maternal glucose tolerance test.
  2. Detailed anatomy scan: stomach, face and jaw, brain, limbs and movement, hydrops; middle cerebral artery Doppler for anemia.
  3. Maternal antibody screen; infection serology (CMV, parvovirus B19) when the scan suggests infection.
  4. Karyotype and chromosomal microarray with anomalies, growth restriction, or aneuploidy markers; exome, ideally as a trio, when the array is normal.
  5. Examine the mother for grip myotonia and offer DMPK repeat testing when there is concern.

Oligohydramnios

  1. Rule out ruptured membranes: speculum exam, nitrazine and ferning, or a placental alpha-microglobulin-1 test.
  2. Scan the kidneys and bladder, rescanning at 30-minute intervals if the bladder is empty; color Doppler for renal arteries; fetal MRI when views are poor.
  3. Growth and umbilical artery Doppler; medication history (ACE inhibitors, ARBs, NSAIDs).
  4. Karyotype and microarray for bilateral renal involvement or another anomaly; isolated renal anomalies do not raise the aneuploidy risk.
  5. Parental renal ultrasound before giving a recurrence risk; bank fetal and parental DNA.
  • Urine in, swallowing out. Every cause sits on one side of that balance, or is a leak.
  • Congenital myotonic dystrophy comes from the mother: with neuromuscular signs and 200 to 500 repeats, her risk of a congenitally affected child is 10% to 30%, and 40% to 50% after one affected child.
  • Parental kidneys answer the recurrence question: normal in recessive ARPKD; a parent with cysts points to dominant ADPKD, which rarely presents before birth.